Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Metagenomi Therapeutics, Inc. Common Stock · MGX

MGXNASDAQCommon stockCurrentCIK 1785279Updated Nov 18, 2026

Company: Metagenomi Therapeutics, Inc. →

Name history
Metagenomi, Inc. · through Jan 12, 2026Metagenomi Technologies, LLC · through Jan 18, 2024

MGX price & chart

Provider market data

Loading TradingView…

NASDAQ:MGX on TradingView ↗

TradingView · Data may be delayed

About the company

Metagenomi Therapeutics, Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create potentially curative genetic medicines for patients. The Company was founded on the science of metagenomics, the study of genetic materials recovered from the natural environment, to discover and develop a suite of novel CRISPR gene-editing tools potentially capable of correcting any type of genetic mutation found anywhere in the human genome. The Company focuses on high value programs in disease indications with well-understood biology and clearly defined clinical development and regulatory pathways. Going forward, the Company intends to continue to expand its pipeline by leveraging its proprietary genetic editing capabilities in site-specific deletion, insertion and correction.

8-K · 2026-11-10 · 0001193125-26-455436

Company description from the cited filing.

In the news

No coverage from other publishers is available.

Seeking Alpha

Recent filings

  1. Regulation FD Disclosure

    Items 7.01, 9.01

    8-K · 2026-11-16 · 0001193125-26-463400

  2. 10-Q filing

    10-Q · 2026-11-10 · 0001193125-26-455441

  3. Results of Operations and Financial Condition

    Items 2.02, 9.01

    8-K · 2026-11-10 · 0001193125-26-455436

  4. Regulation FD Disclosure

    Items 7.01, 9.01

    8-K · 2026-09-22 · 0001193125-26-397037

  5. 4 filing

    4 · 2026-09-11 · 0001193125-26-389550

Show 5 more recent filings
  1. SCHEDULE 13G - filed by Thomas Brian C. regarding Metagenomi Therapeutics, Inc.

    SCHEDULE 13G · 2026-09-10 · 0001193125-26-387853

  2. 10-Q filing

    10-Q · 2026-08-10 · 0001193125-26-342400

  3. Results of Operations and Financial Condition

    Items 2.02, 9.01

    8-K · 2026-08-10 · 0001193125-26-342388

  4. 4 filing

    4 · 2026-06-11 · 0001193125-26-267272

  5. 4 filing

    4 · 2026-06-11 · 0001193125-26-267255

Financials

FY 2025 · USD
Revenue25,210,000USD · FY 2025
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

Net income-87,868,000USD · FY 2025
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

Operating income-96,013,000USD · FY 2025
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

Diluted EPS-2.36USD per share · FY 2025
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023
ASSETS
AssetsUSD247,937,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

358,348,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

173,701,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

272,284,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

385,905,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

196,953,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

297,866,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

415,403,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

221,103,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

324,599,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

364,842,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Property, Plant and Equipment, NetUSD13,895,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

19,719,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

9,896,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

15,113,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

20,711,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

11,160,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

16,521,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

20,960,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

12,288,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

17,740,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

21,542,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD32,773,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

25,117,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2024-09-30

39,028,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

26,850,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2025-06-30

61,181,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2024-06-30

25,306,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

29,195,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2025-03-31

102,558,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2024-03-31

41,722,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

27,386,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

140,603,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Assets, CurrentUSD189,820,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

282,293,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

124,468,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

211,681,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

307,579,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

144,558,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

233,195,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

335,643,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

165,538,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

257,960,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

278,273,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Prepaid Expense and Other Assets, CurrentUSD4,746,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

7,117,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

3,804,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

5,815,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

6,010,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

4,396,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

6,213,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

6,156,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

4,434,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

8,396,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

4,640,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Operating Lease, Right-of-Use AssetUSD36,011,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

40,191,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

31,772,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

37,283,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

41,359,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

33,761,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

38,674,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

42,497,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

35,094,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

39,917,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

43,611,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Other Assets, NoncurrentUSD809,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

320,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

1,018,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

805,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

332,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

927,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

781,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

379,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

836,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

287,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

5,492,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD69,490,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

102,575,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

61,134,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

76,453,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

116,486,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

59,168,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

85,208,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

139,770,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

62,507,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

89,742,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

149,668,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Commitments and ContingenciesUSD—————————0
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

0
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD0
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

0
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

0
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

0
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

0
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

0
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

0
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

0
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

0
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

0
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

0
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Common Stock, Value, IssuedUSD4,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

4,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

4,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

4,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

4,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

4,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

4,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

4,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

4,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

4,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

0
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Additional Paid in CapitalUSD466,414,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

453,734,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

474,096,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

463,404,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

450,511,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

471,754,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

460,074,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

445,999,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

469,202,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

457,146,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

9,457,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Retained Earnings (Accumulated Deficit)USD-288,342,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

-199,604,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

-361,411,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

-267,949,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

-180,831,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

-333,929,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

-248,041,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

-170,092,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

-310,870,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

-223,002,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

-144,944,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD371,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

1,639,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

-122,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

372,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

-265,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

-44,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

621,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

-278,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

260,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

709,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

-97,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Stockholders' Equity Attributable to ParentUSD178,447,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

255,773,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2024-09-30

112,567,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

195,831,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2025-06-30

269,419,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2024-06-30

137,785,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

212,658,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2025-03-31

275,633,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2024-03-31

158,596,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

234,857,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

-135,584,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Liabilities and EquityUSD247,937,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

358,348,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

173,701,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

272,284,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

385,905,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

196,953,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

297,866,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

415,403,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

221,103,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

324,599,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

364,842,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Current liabilities:
Liabilities, CurrentUSD29,583,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

45,692,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

27,632,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

33,265,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

52,810,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

22,499,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

39,893,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

70,701,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

22,933,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

37,309,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

68,861,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Operating Lease, Liability, CurrentUSD5,571,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

4,696,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

6,235,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

5,508,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

5,396,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

6,105,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

5,603,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

4,382,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

6,025,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

5,592,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

3,427,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Accounts Payable, CurrentUSD1,215,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

3,103,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

2,603,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

2,891,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

3,453,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

2,398,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

2,670,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

6,843,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

1,489,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

533,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

1,791,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Operating Lease, Liability, NoncurrentUSD36,092,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

41,377,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

31,485,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

37,482,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

42,545,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

33,081,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

38,834,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

43,680,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

34,632,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

40,186,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

44,802,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Other Liabilities, NoncurrentUSD1,919,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

3,075,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

2,017,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

2,153,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

3,803,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

1,953,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

2,109,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

5,079,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

1,953,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

2,010,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

5,079,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Additional Financial Items
Cash, Cash Equivalents, and Short-term InvestmentsUSD184,100,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

274,600,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

120,700,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

205,000,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

299,900,000
Source

10-Q · 2024-08-14 · 0000950170-24-096665

As of 2024-06-30

140,200,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

226,000,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

327,400,000
Source

10-Q · 2024-05-14 · 0000950170-24-059504

As of 2024-03-31

160,800,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

248,300,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

—
Accounts Receivable, after Allowance for Credit Loss, Current———
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

—
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

——
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

—
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

————

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD———————-25,039,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

2025-01-01 to 2025-03-31

-87,868,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-78,058,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-68,255,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD——————2,552,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

2,928,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

11,853,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

16,204,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

6,922,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD——————-305,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-245,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-952,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-1,194,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

2,451,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Increase (Decrease) in Accounts PayableUSD——————795,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

2,210,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

1,054,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-1,106,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-84,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-21,175,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-22,842,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-88,892,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-109,073,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-91,409,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————3,986,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

24,728,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

103,529,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-88,157,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

45,734,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————25,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

288,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

574,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

3,114,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

9,814,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————-27,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-77,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-356,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

84,013,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

1,012,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-17,216,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

1,809,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

14,281,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-113,217,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-44,663,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——38,021,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

30,365,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2024-09-30

43,421,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

32,098,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2025-06-30

29,699,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

34,443,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2025-03-31

46,915,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

32,634,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

145,851,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2023-12-31

Supplemental disclosure of cash flow information:
Income Taxes Paid, NetUSD————————-2,238,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

3,505,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

2,250,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——3,010,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

3,223,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

2,268,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

3,221,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

2,552,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

2,928,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

11,853,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

16,204,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

6,922,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD——184,100,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

As of 2025-09-30

274,600,000
Source

10-Q · 2024-11-13 · 0000950170-24-126273

As of 2024-09-30

120,700,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

As of 2026-06-30

205,000,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

As of 2025-06-30

140,200,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

As of 2026-03-31

226,000,000
Source

10-Q · 2025-05-13 · 0000950170-25-070463

As of 2025-03-31

160,800,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

As of 2025-12-31

248,300,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

As of 2024-12-31

—
DepreciationUSD——————1,275,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

1,358,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

5,317,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

5,407,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

4,207,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Gain (Loss) on Disposition of AssetsUSD————————-502,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

——
General and Administrative ExpenseUSD——6,215,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

7,641,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

6,004,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

6,993,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

6,535,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

6,805,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

26,790,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

32,017,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

28,845,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Income Tax Expense (Benefit)USD——-234,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-2,106,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

0
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

44,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

10,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

98,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-58,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-5,513,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

8,027,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Investment Income, InterestUSD——2,214,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

3,616,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

1,256,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

2,485,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

1,539,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

2,887,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

9,470,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

14,722,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

15,468,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Net Income (Loss) Attributable to ParentUSD——-20,393,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-18,773,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

-27,482,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

-19,908,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

-23,059,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-25,039,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-87,868,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-78,058,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-68,255,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——-20,393,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-18,773,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

-27,482,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

-19,908,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

-23,059,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-25,039,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-87,868,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-78,058,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-68,255,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Nonoperating Income (Expense)USD——2,212,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

1,504,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

1,291,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

1,123,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

1,538,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

2,879,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

8,087,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

5,330,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

18,264,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Operating ExpensesUSD——31,498,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

33,897,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

28,516,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

29,500,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

25,835,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

31,947,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

121,223,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

141,196,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

123,248,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Operating Lease, ExpenseUSD——————1,335,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

1,273,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

5,318,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

4,644,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

4,207,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Other Nonoperating Income (Expense)USD——-2,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-57,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

35,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

-70,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

-1,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-8,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-91,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-207,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-74,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Payments of Financing CostsUSD——————27,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

77,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

558,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

——
Fair Value, Option, Changes in Fair Value, Gain (Loss)——————
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

—————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023
Total RevenueUSD——8,659,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

11,514,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

—8,513,000
Source

10-Q · 2025-08-12 · 0000950170-25-107308

2025-04-01 to 2025-06-30

1,248,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

4,127,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

25,210,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

52,295,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

44,756,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Operating Income (Loss)USD——-22,839,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-22,383,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

-28,773,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

-20,987,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

-24,587,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-27,820,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-96,013,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-88,901,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-78,492,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Other Nonoperating Income (Expense)USD——-2,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-57,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

35,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

-70,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

-1,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-8,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-91,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-207,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-74,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——-20,627,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-20,879,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

-27,482,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

-19,864,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

-23,049,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-24,941,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-87,926,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-83,571,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-60,228,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Income Tax Expense (Benefit)USD——-234,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-2,106,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

0
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

44,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

10,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

98,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-58,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-5,513,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

8,027,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Net Income (Loss) Attributable to ParentUSD——-20,393,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-18,773,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

-27,482,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

-19,908,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

-23,059,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-25,039,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-87,868,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-78,058,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-68,255,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Earnings Per Share, BasicUSD per share——-0.55
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-0.51
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

-0.73
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

-0.54
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

-0.61
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-0.68
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-2.36
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-2.36
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-20.05
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Earnings Per Share, DilutedUSD per share——-0.55
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-0.51
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

-0.73
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

-0.54
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

-0.61
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-0.68
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-2.36
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-2.36
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-20.05
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Weighted Average Number of Shares Outstanding, Basicshares——37,349,449
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

36,766,309
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

37,658,250
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

37,156,979
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

37,581,094
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

37,019,027
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

37,251,050
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

33,027,889
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

3,404,585
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——37,349,449
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

36,766,309
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

37,658,250
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

37,156,979
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

37,581,094
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

37,019,027
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

37,251,050
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

33,027,889
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

3,404,585
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Additional Financial Items
Current Income Tax Expense (Benefit)USD————————-58,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-5,513,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

8,027,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecreaseUSD————————0
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

——
General and Administrative ExpenseUSD——6,215,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

7,641,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

6,004,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

6,993,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

6,535,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

6,805,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

26,790,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

32,017,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

28,845,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-87,926,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-83,571,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-60,228,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Investment Income, InterestUSD——2,214,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

3,616,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

1,256,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

2,485,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

1,539,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

2,887,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

9,470,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

14,722,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

15,468,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——-20,393,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

-18,773,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

-27,482,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

-19,908,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

-23,059,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

-25,039,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

-87,868,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

-78,058,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

-68,255,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Nonoperating Income (Expense)USD——2,212,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

1,504,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

1,291,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

1,123,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

1,538,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

2,879,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

8,087,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

5,330,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

18,264,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Operating ExpensesUSD——31,498,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

33,897,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

28,516,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

29,500,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

25,835,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

31,947,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

121,223,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

141,196,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

123,248,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Operating Lease, ExpenseUSD——————1,335,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

1,273,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

5,318,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

4,644,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

4,207,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Research and Development ExpenseUSD——25,283,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2025-07-01 to 2025-09-30

26,256,000
Source

10-Q · 2025-11-12 · 0001193125-25-276150

2024-07-01 to 2024-09-30

22,512,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2026-04-01 to 2026-06-30

22,507,000
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

19,300,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2026-01-01 to 2026-03-31

25,142,000
Source

10-Q · 2026-05-11 · 0001193125-26-216774

2025-01-01 to 2025-03-31

94,433,000
Source

10-K · 2026-03-05 · 0001193125-26-093976

2025-01-01 to 2025-12-31

109,179,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2024-01-01 to 2024-12-31

94,403,000
Source

10-K · 2025-03-17 · 0000950170-25-040217

2023-01-01 to 2023-12-31

Fair Value, Option, Changes in Fair Value, Gain (Loss)——————
Source

10-Q · 2026-08-10 · 0001193125-26-342400

2025-04-01 to 2025-06-30

—————

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

mgx-ex99_1.htm · 8-K · 2026-11-16

Precision gene editing designed to deliver durable, curative medicines Corporate Presentation November 2026 This presentation includes forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation are forward looking statements, including the timing of and our ability to make regulatory filings such as INDs, the design and timing…

8-K · 2026-11-16 · 0001193125-26-463400

Read attachment ↗
mgx-ex99_1.htm · 8-K · 2026-11-10

Exhibit 99.1 Metagenomi Therapeutics Announces FDA Clearance of Investigational New Drug Application for MGX-001 and Reports Third Quarter 2026 Financial Results FDA clearance enables initiation of a first-in-human Phase 1/2 trial of MGX-001 in patients with hemophilia A MGX-001 is designed to deliver durable, endogenous Factor VIII (FVIII) activity from a one-time treatment for adults and children Company plans to initiate the INTEGR8 clinical trial in the first half of 2027 and provide ini…

8-K · 2026-11-10 · 0001193125-26-455436

Read attachment ↗
mgx-ex99_1.htm · 8-K · 2026-09-22

Precision gene editing designed to deliver durable, curative medicines Corporate Presentation September 2026 This presentation includes forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation are forward looking statements, including statements regarding our cash runway, strategy and plans, industry environment, potential gr…

8-K · 2026-09-22 · 0001193125-26-397037

Read attachment ↗
mgx-ex99_1.htm · 8-K · 2026-08-10

EX-99.1 2 mgx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results Remains on track to submit investigational new drug (IND) application in 4Q 2026 for the global clinical program of MGX-001 for the treatment of hemophilia A $120.7 million in cash, cash equivalents, and available-for-sale marketable securities as of June 30, 2026, with runway anticipated to support operations through 4Q 2027 EMERYVILLE, Calif.…

8-K · 2026-08-10 · 0001193125-26-342388

Read attachment ↗
mgx-ex99_1.htm · 8-K · 2026-05-11

EX-99.1 2 mgx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results On track for regulatory submission of MGX-001 to advance global clinical program, including investigational new drug application (“IND”) in 4Q 2026 Publication in Nature Structural & Molecular Biology highlights potential of MG119-28, a proprietary compact CRISPR nuclease with enhanced genome editing efficiency $140.2 million in cash, cash equiv…

8-K · 2026-05-11 · 0001193125-26-216763

Read attachment ↗
mgx-ex99_2.htm · 8-K · 2026-05-11

EX-99.2 3 mgx-ex99_2.htm EX-99.2 Precision gene editing designed to deliver durable, curative medicines Hemophilia A lead program | IND 2026 Corporate Presentation May 2026 This presentation includes forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation are forward looking statements, including statements regarding ou…

8-K · 2026-05-11 · 0001193125-26-216763

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.